Purine nucleotide antiveral composition and methods of use

Details Purine nucleotide antiveral composition and methods of use Purine nucleotide antiveral composition and methods of use

1976-06-16

1979-01-23

Brown, Johnnie R.

Drug, bio-affecting and body treating compositions

Conjugate or complex of monoclonal or polyclonal antibody,...

Conjugated via claimed linking group, bond, chelating agent,...

195 28N, 195 80R, 536 27, 536 28, A61K 3152, C07C 1920

Patent

active

041361750

ABSTRACT:
The nucleotide derivatives of certain 2,6 substituted purines have been discovered to have anti-viral activity. Novel compounds and their pharmaceutically acceptable salts, pharmaceutical formulations containing the compounds of this invention, and the treatment of viral infections with these formulations are all disclosed. 2,6 Diamino-9-(.beta.-D arabinofuranosyl)-purine-5'-phosphate is an example of a more active compound of this invention.

REFERENCES:
patent: 3300478 (1967-01-01), Wechter
patent: 3328389 (1967-06-01), Shimizu et al.
patent: 3337530 (1967-08-01), Hanze
patent: 3382232 (1968-05-01), Honjo et al.
patent: 3448098 (1969-06-01), Gaines et al.
patent: 3666856 (1972-05-01), Elion et al.
patent: 3703507 (1972-11-01), Haskell et al.

Affiliated with

Also associated with

Rating

Purine nucleotide antiveral composition and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Purine nucleotide antiveral composition and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purine nucleotide antiveral composition and methods of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2273366